CEA-Scan MoAb agent cleared in Europe

Immunomedics of Morris Plains, NJ, last week announced that it

has received clearance from the European Commission to market

its CEA-Scan colorectal cancer imaging agent in the 15 countries

of the European Union. The monoclonal-antibody-based agent received

U.S. clearance in June (SCAN 7/17/96). Mallinckrodt Medical of

St. Louis has marketing rights to CEA-Scan in both the U.S. and

Europe.